Table 3 Multivariate analysis of overall survival
From: Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
Prognostic factor | β | P | Relative risk | 95% confidence interval |
|---|---|---|---|---|
Overall histology | ||||
Tumor MMP-9 expression | 0.043 | 0.807 | 1.044 | 0.741–1.469 |
Lymphovascular invasion | 0.661 | 0.005 | 1.937 | 1.219–3.078 |
Pathologic stage (I vs. II) | 0.904 | 0.000 | 2.469 | 1.686–3.616 |
Pathologic stage (I vs. IIIA) | 1.123 | 0.000 | 3.073 | 1.938–4.875 |
Squamous cell carcinoma | ||||
Tumor MMP-9 expression | −0.419 | 0.196 | 0.658 | 0.349–1.241 |
Adenocarcinoma | ||||
Tumor MMP-9 expression | 0.295 | 0.259 | 1.343 | 0.805–2.242 |